Catalyst Wire Dossier Catalyst Wire Dossier

Ebilfumin

oseltamivir · Actavis Group PTC ehf
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ebilfumin, covering 2025-09-02 to 2025-09-02. Get the full timeline:

Most recent: EMA Authorised: Ebilfumin (oseltamivir) — Actavis Group PTC ehf

See pricing